2023年8月2日,

分享Axial3D,一個領導者在醫學分割和三維解決方案宣布它是第一個獲得FDA批準的自動化,AI-driven,雲分割平台骨科創傷、骨科、頜麵、和心血管應用程序。這一成就是第二個FDA批準Axial3D細分平台已經收到,洞察力,和醫療行業的一個重要裏程碑的自動化和人工智能個性化病人護理。FDA批準預計將提供一個重大推動對擴大生產過程特別是醫療設備公司。“我們祝賀Axial3D獲得FDA批準的細分平台,利用自動化和人工智能的力量作為一個關鍵業務驅動的醫療行業的持續成功。“分化的AWS雲基礎設施、人工智能算法和先進的機器學習技術,Axial3D洞察力自動化2 d DICOM圖像的轉換過程,如CT和MRI掃描成精確的3 d可視化,3 d打印文件,3 d網格文件,或3 d印刷解剖模型,用Stratasys公司打印技術。通過自動化手工或半手工的傳統的艱苦和耗時的任務圖像分割,Axial3D使衛生保健提供者和醫療設備公司滿足更多的應用程序,同時節省幾小時或幾天內每箱,減少資本支出。“我們的食品及藥物管理局批準為Axial3D洞察力™是一個證明Axial3D已經走了多遠,“丹•克勞福德表示Axial3D的創始人和方案。“從我們創業的卑微到現在被認為是一個領先的醫療科技公司,這一成就展示了我們致力於推動醫療創新的邊界。我們無比自豪的團隊的承諾在提供特殊病人護理使用先進自動化、人工智能和機器學習技術。“相關文章通過實現自動化和人工智能工作流,Axial3D與強大的工具裝備衛生保健專業人士更容易和更快的訪問病人數據在3 d和發展計劃。 More visible patient data in 3D enables surgeons to enhance diagnostic accuracy, treatment planning, and surgical intervention. The Axial INSIGHT™ platform also allows medical device companies the ability to accelerate their patient-specific programs quickly by being able to process more patient data with the same resources. This 3D data can then be used to design personalized devices and surgical kits that include surgical plans, models, and surgical guides, that can be 3D printed on a variety of printers including Stratasys systems from Digital Anatomy 3D printers to production-scale additive manufacturing systems. Stratasys Ltd.led an investment round in late 2022 to help advance Axial3D’s technology and to bring a joint solution to market for healthcare providers and medical device manufacturers. “Stratasys is proud to partner with Axial3D in driving innovation and in transforming the healthcare landscape with 3D solutions that help make personalized healthcare at scale possible,” said Stratasys CEO Dr. Yoav Zeif. “We congratulate Axial3D on achieving FDA clearance for their segmentation platform, leveraging the power of automation and AI as a key business driver for their continued success in the medical sector.